Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4

Microbes and Infection

Volumn 15, Issue 1, 2013, Pages 18-27

  Goffard, A ^a   Alidjinou, E K ^a   Sane F ^a   Choteau, L ^a   Bouquillon, C ^a   Caloone, D ^a   Lobert, P E ^a   Hober, D ^a  

^a University Lille   (France)

Author keywords

Alpha interferon; Coxsackievirus B4; Infection; Monocyte; THP 1

Indexed keywords

ANTIBODY; GAMMA INTERFERON; PHORBOL ESTER; VIRUS RNA;

ARTICLE; CELL CULTURE; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

CELLS, CULTURED; COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULINS; INTERFERON-ALPHA; INTRACELLULAR SPACE; MONOCYTES; RECEPTORS, IGG; T-LYMPHOCYTES, HELPER-INDUCER; TETRADECANOYLPHORBOL ACETATE;

COXSACKIEVIRUS;

EID: 84871813938     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.10.005     Document Type: Article

References (50)

1. Hober D., Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 2010, 6:279-289.
2. Poh C.L., Tan E.L. Detection of enteroviruses from clinical specimens. Diagnostic Virology Protocols 2010, 65-77. Humana Press, Totowa. J.R. Stephenson, A. Warnes (Eds.).
3. Tan E.L., Wong A.P.Y., Poh C.L. Development of potential antiviral strategy against coxsackievirus B4. Virus. Res. 2010, 150:85-92.
4. Ramsingh A.I. CVB-induced pancreatitis and alterations in gene expression. Curr. Top. Microbiol. Immunol. 2008, 323:241-258.
5. Chapman N.M., Kim K.S. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008, 323:275-292.
6. Schanen C., Nasri D., Bourlet T., Barral X., Favre J.P., Bourrat D., Péoc'h M., Ginevra C., Andréoletti L., Pozzetto B., Pillet S. Enterovirus in arteriosclerosis: a pilot study. J. Clin. Virol. 2007, 39:106-112.
7. Yeung W.C.G., Rawlinson W.D., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011, 342:d35.
8. Hober D., Sane F. Enteroviruses and type 1 diabetes. BMJ 2011, 342 c7072.
9. Jaïdane H., Sauter P., Sane F., Goffard A., Gharbi J., Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev. Med. Virol. 2010, 20:265-280.
10. Dahlquist G.G., Forsberg J., Hagenfeldt L., Boman J., Juto P. Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based case-control study. Diabetes Care 2004, 27:285-286.
11. Moya-Suri V., Schlosser M., Zimmermann K., Rjasanowski I., Gürtler L., Mentel R. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J. Med. Microbiol. 2005, 54:879-883.
12. Craig M.E., Howard N.J., Silink M., Rawlinson W.D. Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J. Infect. Dis. 2003, 187:1562-1570.
13. Schulte B.M., Bakkers J., Lanke K.H.W., Melchers W.J.G., Westerlaken C., Allebes W., Aanstoot H.J., Bruining G.J., Adema G.J., Van Kuppeveld F.J.M., Galama J.M.D. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol. 2010, 23:99-104.
14. Chehadeh W., Weill J., Vantyghem M.C., Alm G., Lefèbvre J., Wattré P., Hober D. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J. Infect. Dis. 2000, 181:1929-1939.
15. Wahid R., Cannon M.J., Chow M. Dendritic cells and macrophages are productively infected by poliovirus. J. Virol. 2005, 79:401-409.
16. Vuorinen T., Vainionpää R., Heino J., Hyypiä T. Enterovirus receptors and virus replication in human leukocytes. J. Gen. Virol. 1999, 80:921-927.
17. Hofmann P., Schmidtke M., Stelzner A., Gemsa D. Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection. J. Med. Virol. 2001, 64:487-498.
18. Frisk G., Friman G., Tuvemo T., Fohlman J., Diderholm H. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992, 35:249-253.
19. Littaua R., Kurane I., Ennis F.A. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 1990, 144:3183-3186.
20. Tamura M., Webster R.G., Ennis F.A. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology 1991, 182:211-219.
21. Takeda A., Sweet R.W., Ennis F.A. Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J. Virol. 1990, 64:5605-5610.
22. Sauter P., Hober D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect. 2009, 11:443-451.
23. Chehadeh W., Bouzidi A., Alm G., Wattré P., Hober D. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro. J. Gen. Virol. 2001, 82:1899-1907.
24. Hober D., Chehadeh W., Bouzidi A., Wattré P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis. J. Infect. Dis. 2001, 184:1098-1108.
25. Hober D., Chehadeh W., Weill J., Hober C., Vantyghem M.-C., Gronnier P., Wattré P. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes. J. Gen. Virol. 2002, 83:2169-2176.
26. Chehadeh W., Lobert P.-E., Sauter P., Goffard A., Lucas B., Weill J., Vantyghem M.-C., Alm G., Pigny P., Hober D. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J. Virol. 2005, 79:13882-13891.
27. Hober D., Sane F., Jaïdane H., Riedweg K., Goffard A., Desailloud R. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin. Exp. Immunol. 2012, 168:47-51.
28. Strauss-Ayali D., Conrad S.M., Mosser D.M. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 2007, 82:244-252.
29. Weinshenker B.G., Wilton S., Rice G.P. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J. Immunol. 1988, 140:1625-1631.
30. Delannoy A.S., Hober D., Bouzidi A., Wattre P. A macrophage-like cell model for testing anti-CMV drugs. Pathol. Biol. 1997, 45:394-399.
31. Lobert P.E., Hober D., Dewilde A., Wattré P. Cell membrane bound N-acetylneuraminic acid is involved in the infection of fibroblasts and phorbol-ester differentiated monocyte-like cells with human cytomegalovirus (HCMV). Arch. Virol. 1995, 140:1357-1371.
32. Yew K.-H., Carsten B., Harrison C. Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells. Mol. Immunol. 2010, 47:883-893.
33. Padwad Y.S., Mishra K.P., Jain M., Chanda S., Ganju L. Dengue virus infection activates cellular chaperone Hsp70 in THP-1 cells: downregulation of Hsp70 by siRNA revealed decreased viral replication. Viral Immunol. 2010, 23:557-565.
34. Shattock R.J., Friedland J.S., Griffin G.E. Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells. J. Gen. Virol. 1994, 75:849-856.
35. Emori Y., Ikeda T., Ohashi T., Masuda T., Kurimoto T., Takei M., Kannagi M. Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages. J. Gen. Virol. 2004, 85:2603-2613.
36. Kettle S., Alcamí A., Khanna A., Ehret R., Jassoy C., Smith G.L. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J. Gen. Virol. 1997, 78:677-685.
37. Mori S., Takeuchi T., Kanda T. Antibody-dependent enhancement of adeno-associated virus infection of human monocytic cell lines. Virology 2008, 375:141-147.
38. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982, 42:1530-1536.
39. Fleit H.B., Kobasiuk C.D. The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII. J. Leukoc. Biol. 1991, 49:556-565.
40. Tridandapani S., Wardrop R., Baran C.P., Wang Y., Opalek J.M., Caligiuri M.A., Marsh C.B. TGF-beta 1 suppresses myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. J. Immunol. 2003, 170:4572-4577.
41. Estrella J.L., Kan-Sutton C., Gong X., Rajagopalan M., Lewis D.E., Hunter R.L., Eissa N.T., Jagannath C. A novel in vitro human macrophage model to study the persistence of Mycobacterium tuberculosis using vitamin D(3) and retinoic acid activated THP-1 macrophages. Front. Microbiol. 2011, 2:67.
42. Chehadeh W., Kerr-Conte J., Pattou F., Alm G., Lefebvre J., Wattré P., Hober D. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol. 2000, 74:10153-10164.
43. Cederblad B., Blomberg S., Vallin H., Perers A., Alm G.V., Rönnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J. Autoimmun. 1998, 11:465-470.
44. Gessner J.E., Heiken H., Tamm A., Schmidt R.E. The IgG Fc receptor family. Ann. Hematol. 1998, 76:231-248.
45. Daëron M. Fc receptor biology. Ann. Rev. Immunol. 1997, 15:203-234.
46. Kramer P.R., Kramer S.F., Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 2004, 50:1967-1975.
47. Bhatia A., Blades S., Cambridge G., Edwards J.C. Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments. Immunology 1998, 94:56-63.
48. Fanger M.W., Shen L., Graziano R.F., Guyre P.M. Cytotoxicity mediated by human Fc receptors for IgG. Immunol. Today 1989, 10:92-99.
49. Kameoka M., Kimura T., Okada Y., Fujinaga K., Nakaya T., Takahashi H., Kishi M., Ikuta K. High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA. Virus Genes 1996, 12:117-129.
50. Okada Y., Toda G., Oka H., Nomoto A., Yoshikura H. Poliovirus infection of established human blood cell lines: relationship between the differentiation stage and susceptibility of cell killing. Virology 1987, 156:238-245.